Chemical inhibitors of Sox-14 include a range of molecules that interfere with various cellular pathways and molecular interactions essential for the full functional expression of Sox-14. Chetomin disrupts the interaction between Sox-14 and hypoxia-inducible factor (HIF), a necessary partner for Sox-14 during hypoxia-induced DNA binding events. Similarly, YC-1, Echinomycin, and PX-478 all target the HIF-1alpha pathway, which is crucial for the transcriptional regulation activity of Sox-14 under low oxygen conditions. By inhibiting HIF-1alpha activation or its expression, these chemicals impede the regulatory functions of Sox-14 that are mediated through the HIF pathway. KC7F2, another HIF-1alpha inhibitor, reduces the translation of HIF-1alpha, subsequently lowering the influence of HIF-1alpha on Sox-14's activity.
Complementing these HIF-targeted inhibitors, CAY10585 and C646 interfere with the acetylation process essential for Sox-14's transcriptional activity. CAY10585 inhibits the histone acetyltransferase p300, which is necessary for acetylation of histones near Sox-14 binding sites, while C646 is a more selective inhibitor of the same enzyme, impeding the acetylation that enhances Sox-14's DNA binding and transcriptional regulation. Acriflavine prevents HIF-1 dimerization and DNA binding, thus potentially limiting Sox-14's interaction with HIF-1 and its subsequent transcriptional regulatory activities. Cardamonin targets the NF-kB pathway, which intersects with Sox-14's regulatory pathways, and by inhibiting NF-kB, it consequently curtails Sox-14's ability to regulate genes that are co-regulated by NF-kB. Lastly, Ro 31-8220 inhibits protein kinase C, which is implicated in the phosphorylation and subsequent activation of Sox-14; by blocking this phosphorylation, Ro 31-8220 effectively inhibits the functional activity of Sox-14. These chemicals collectively contribute to the inhibition of Sox-14 by targeting the protein's interaction with HIF-1, histone acetylation processes, and phosphorylation events that are requisite for its regulatory function within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $182.00 $661.00 | 10 | |
Chetomin disrupts the function of hypoxia-inducible factor (HIF), which Sox-14 requires for proper DNA binding under hypoxic conditions. Inhibition of HIF can thus impair Sox-14's DNA binding capability and function. | ||||||
YC-1 | 170632-47-0 | sc-202856 sc-202856A sc-202856B sc-202856C | 1 mg 5 mg 10 mg 50 mg | $32.00 $122.00 $214.00 $928.00 | 9 | |
YC-1 inhibits HIF-1alpha activation, which is necessary for Sox-14 to regulate genes under hypoxic conditions. This inhibition can prevent Sox-14 from exerting its gene regulatory functions. | ||||||
Quinomycin A | 512-64-1 | sc-202306 | 1 mg | $163.00 | 4 | |
Quinomycin A is a small molecule inhibitor of the HIF-1 DNA-binding activity, which could inhibit the interaction between Sox-14 and its target hypoxia response elements on DNA. | ||||||
PX-478 | 685898-44-6 | sc-507409 | 10 mg | $175.00 | ||
PX-478 is known to inhibit the expression of HIF-1alpha. By reducing HIF-1alpha levels, it can indirectly inhibit the function of Sox-14 which may rely on HIF-mediated transcriptional activation processes. | ||||||
Hypoxia inducible factor-1α inhibitor | 934593-90-5 | sc-205346 sc-205346A sc-205346B sc-205346C | 1 mg 5 mg 10 mg 25 mg | $32.00 $112.00 $190.00 $403.00 | 40 | |
CAY10585 inhibits histone acetyltransferase p300, which is necessary for the transcriptional activity of Sox-14 through acetylation of histones near the Sox-14 binding sites on DNA. | ||||||
N-([1,1′-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine | 1357171-62-0 | sc-503580 | 1 mg | $245.00 | ||
ML228 acts as an inhibitor of HIF-1alpha and can thus inhibit Sox-14's functionality that relies on the HIF-1 pathway for the hypoxic response. | ||||||
Acriflavine | 8048-52-0 | sc-214489 sc-214489A | 25 g 100 g | $49.00 $168.00 | 2 | |
Acriflavine inhibits HIF-1 dimerization and DNA binding, thus potentially inhibiting Sox-14's interaction with HIF-1 and its consequent DNA-binding and transcriptional regulatory activities. | ||||||
Cardamonin | 19309-14-9 | sc-293984 sc-293984A | 10 mg 50 mg | $220.00 $922.00 | ||
Cardamonin inhibits the NF-kB pathway, which can intersect with Sox-14 regulatory pathways, inhibiting the ability of Sox-14 to regulate genes that are also controlled by NF-kB. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
C646 is a selective inhibitor of p300, a histone acetyltransferase that can acetylate Sox-14, thereby reducing its DNA-binding ability and inhibiting its function. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $90.00 $240.00 | 17 | |
Ro 31-8220 inhibits protein kinase C, which is involved in the phosphorylation of Sox-14, a modification that can be crucial for its activity; inhibition of this phosphorylation can inhibit Sox-14 function. | ||||||